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ABSTRACT 
Ondansetron hydrochloride is a selective 5-HT3 receptor antagonist, used in the management of nausea and vomiting 
induced  by  cytotoxic  chemotherapy  and  radiograpy  it  is  also  used  for  prevention  of  postoperative  nausea  and 
vomiting in adults. But it is a better drug. In this research work main aim to mask the taste and to formulate rapid 
disintegrating tablets using superdisintigrating agents, crospovidone (upto3%), Croscarmellose sodium (up to 5%), 
and Aminoalkyl methacrylate copolymer (Eudragit EPO) as taste masking agent. It is suitable dosage for pediatric 
and geriatric patients. Estimation of Ondansetron hydrochloride in the prepared tablets was carried out by extracting 
the drug with methanol and measuring the absorbance at 310nm. The prepared tablets were further evaluated for 
hardness, friability, drug content, uniformity, in vitro dissolution time, wetting time and water absorption ratio. One 
promising formulation was tested in vitro drug release pattern in phosphate buffer pH 6.8 
KEY  WORDS:  rapid  disintegrating  tablets,  crospovididone,  croscarmellose  sodium,  sodium  starch  glycolate, 
Eudragit EPO, Ondansetron hydrochloride.  
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INTRODUCTION  
Tablet is the most widely used solid dosage form because 
of  its  convenience  in  terms  of  self-  administration, 
compactness  and  ease  in  manufacturing.  However, 
geriatric  and  pediatric  patients  experience  difficulty  in 
swallowing  conventional  tablets,  which  leads  to  poor 
patient’s  compliance.  To  overcome  this  Problem, 
scientists have been developed innovative drug delivery 
systems  known  as  rapid  disintegrating  tablets.  Their 
characteristic advantages such as administration without 
water,  any  where,  any  time  lead  to their  suitability  to 
geriatric and pediatric patients. They are also suitable for 
the mentally ill, the bedridden and patients who do not 
have easy access to water
1. 
Ondansetron hydrochloride is a selective 5-HT3 receptor 
antagonist. It is used in the management of nausea and 
vomiting  induced  by  cytotoxic  chemotherapy  and 
radiotherapy.  It  is  also  used  for  prevention  of  post 
operative  nausea  and  vomiting  in  adults.  Ondansetron 
hydrochloride is well absorbed from the gastrointestinal 
tract  and  undergoes  some  first-pass  metabolism.  Mean 
bioavailability  in  healthy  subjects,  following 
administration of a single tablet, is approximately 56%
2. 
The objective of the present investigation was to prepare 
rapid  disintegrating  tablets  of  Ondansetron 
hydrochloride, because in the emesis condition as well as 
in  above  mentioned  specific  conditions,  fast  onset  of 
action and avoidance of water is highly desirable. Tablets 
were  prepared  by  direct  compression  method  using 
Crospovidone  and  Croscarmellose  sodium  as 
superdisintegrants. The combination of these two agents 
gives better disintegration of the dosage form and also 
does not adversely affect compressibility and flowability. 
Mannitol  was  selected  due  to  its  pleasant  mouth  feel 
property, good water dispersibility and binding property. 
It  is  also  an  effective  tablet  disintegrant  and  provides 
good hardness on compaction.  
MATERIALS AND METHODS 
Materials  
Ondansetron  hydrochloride  (OSH)  was  a  gift  sample 
from  Medley  Pharmaceuticals  Ltd.,  Vapi  (Gujarat), 
Microcrystalline Cellulose (MCC), Aspartame, Eudragit 
EPO,  Mint  flavor,  Croscarmellose  Sodium  (CCS), 
Crospovidone  were  a  gift  Sample  from  Zydus  Cadila, 
Ahmedabad.  Mannitol  (Hi  Media  Laboratory  Limited, 
Mumbai),  sodium  saccharine  (Loba  Chemicals, Sharma Dharmendra et al / IJRAP 2011, 2 (1) 259-263 
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Mumbai),  Aerosil  (S.D.  Fine  Chemicals,  Mumbai), 
Magnesium  stearate  (S.D.Fine  Chemicals,  Mumbai) 
were purchased. All other chemicals used were analytical 
grade.  
Preparation of Fast Dissolving Tablets  
Taste masking of the drug  
Ondansetron  HCl  and  Eudragit  EPO  complex  were 
prepared  using  the  precipitation  method.  Saturated 
solutions of Ondansetron HCl  and Eudragit EPO were 
prepared  in  absolute  ethanol  and  injected  into  0.1  N 
sodium hydroxide with constant stirring at 500 rpm in a 
mechanical stirrer. The foamy matrix obtained on the top 
of  the  solution  were  separated  and  dried  at  room 
temperature for 24 hrs under vacuum. The dried matrix 
was subsequently pulverized
3. 
Preparation of Tablet 
By Direct compression method  
The  Drug  Copolymer  Mixture,  pearlitol  SD200 
(Mannitol),  aspartame,  crospovidone 
(superdisintegrants), Aerosil and mixed fruit flavors were 
admixed for about 15 min to make a uniform blend.  
Magnesium stearate was passed through sieve 100 and 
mixed with the above blend for approximately 5-7 min. 
Then tablets were prepared by directly compressed using 
8 mm punch on a single station tablet machine
4, 5. 
Evaluation of Powder Blend  
Bulk density 
Apparent bulk density (g/ml) was determined by placing 
pre-sieved bulk powder blend into a graduated cylinder 
via  a  large  cylinder  and  measuring  the  volume  and 
weight
4. 
Pb = Vb/M 
Tapped density 
Tapped  density  determined  by  placing  a  graduated 
cylinder,  containing  a  known  mass  of  powder  on 
mechanical  tapping  apparatus,  which  was  operated  for 
fixed number of taps (around 250) until the powder bed 
volume reached a minimum. Using the weight of powder 
in  a  cylinder  and  this  minimum  volume,  the  tapped 
density was computed. From the results of bulk density 
and tapped density, Carr’s index was calculated. 
Pt = Vt/M 
Angle of repose 
For the measurement of angle of repose, a glass funnel 
was secured with its tip at a given height (H) above a 
piece  of  graph  paper  placed  on  a  horizontal  surface. 
Powder was poured through the funnel until the apex of 
the conical pile touched the tip of the funnel. The angle 
of repose was calculated with the formula  
tan
-1 = h/r 
Where, tan
-1 is the angle of repose, R is the radius of the 
conical pile. 
Evaluation of Tablets  
Uniformity of weight (Weight Variation) 
Twenty tablets were selected at a random and average 
weight  was  determined.  Then  individual  tablets  were 
weighed and the individual weight was compared with 
an average weight
6. 
Hardness 
The tablet crushing load, which is the force required to 
break a tablet by compression in the radial direction, was 
determined  using  a  Pfizer  hardness  tester  (Sheetal 
Scientific Industries, Mumbai, India). 
Friability 
Friability  of  tablets  was  measured  by  using  Roche 
Friabilator  (Electrolab,  Mumbai,  India).  Friability  was 
evaluated from the percentage weight loss of 20 tablets 
tumbled  in  a  friabilator  at  25 rpm  for  4  minutes.  The 
tablets were deducted, and the loss in weight caused by 
fracture  or  abrasion  was  recorded  as  the  percentage 
weight loss. Friability below 0.5 to 1% was considered 
acceptable. 
In-vitro disintegration time 
The  disintegration  time  was  measured  using  a  paddle 
method  originally  proposed  by  Sunada  et  al.  The 
assembly  utilizes  dissolution  apparatus  USP  XXIII 
paddle apparatus (Electrolab, TDT-06T, Mumbai, India). 
The vessel was filled with 500 ml of water maintained at 
37+2°C and rotated at 100 rpm. The tablet was placed 
inside  the  sinker  and  the  time  at  which  it  passes 
completely through the mesh of sinker was taken as the 
disintegration of the tablet
7. 
In vivo disintegration time 
Measurements of disintegration time in the mouth were 
carried out in six volunteers. After the mouth was rinsed 
with  purified  water, one  tablet  was  held  in  the  mouth 
until the tablet disintegrated without chewing and then 
spat  out  and  the  mouth  was  rinsed  again.  The 
disintegration time was recorded
7. 
Wetting time 
The wetting time of the tablets was  measured  using a 
simple procedure. Five circular tissue papers of 10-cm 
diameter  were  placed  in  a  Petri  dish  with  a  10-cm 
diameter.10 ml of water containing eosin (water-soluble 
dye) was added to the Petri dish. A tablet was carefully 
placed on the surface of tissue paper. The time required 
for water to reach the upper surface of the tablets was 
noted as the wetting time. 
Dissolution study 
The dissolution study was performed for pure drug OSH, 
prepared  batches  and  marketed  conventional  tablet 
formulation  by  using  USP  XXIII  paddle  apparatus 
(Electrolab,  TDT-  06T,  Mumbai).  The  dissolution 
medium was distilled water (900 ml, 37 ± 0.5
0C). The Sharma Dharmendra et al / IJRAP 2011, 2 (1) 259-263 
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rate of agitation of the paddle was 50 rpm. Sample was 
withdrawn at specific time interval of 5 minute, it was 
filtered and absorbance was measured at 310 nm by UV 
spectrophotometer  (UV-1700,  Shimadzu  Corporation, 
Kyoto, Japan)
 8.  
RESULTS AND DISCUSSION 
The  present  investigation  was  undertaken  to  formulate 
and  evaluate  fast  melting  tablets  of  Ondansetron 
hydrochloride  by  direct  compression  method  using 
sodium  starch  glycolate  and  croscarmellose  sodium  as 
superdisintegrants. Superdisintegrants are generally used 
by  formulation  scientists  for  developing  Rapid 
Disintegrating  Tablets  and  fast  melting  tablets  or  for 
improvement  of  solubility  for  active  pharmaceutical 
ingredients.  The  primary  requirement  for  both  dosage 
forms is quicker disintegration. The values obtained for 
bulk  density  and  tapped  density  does  not  affect  the 
compression  of  tablets.  The  angle  of  repose  gives 
important information about the  flow characteristics of 
the powder mixture. The powder flow depends on three 
general areas: the physical properties of the particle (e.g., 
shape, size, compressibility), the bulk powder properties 
(e.g., size distribution, compaction); and the processing 
environment (e.g., storage, humidity) the angle of repose 
<30° indicates free flowing material and >40° with poor 
flow properties. Values for angle of repose were found in 
the range of 26 to 31° showing that the blend of powder 
was free flowing
9.  
The various results for the evaluation of different batches 
of Ondansetron hydrochloride rapid disintegrating tablets 
prepared  by  direct  compression  method  are  shown  in 
Table 2. Percent weight variation was observed between 
5.0+0.54  and  6.0+  0.22  which  were  well  within  the 
acceptable limit for uncoated tablets as per United States 
Pharmacopoeia.  One  of  the  primary  requirements  of 
immediate release preparation is faster disintegration. It 
is well known to formulation scientists that the tablets 
with higher crushing strength show longer disintegration 
time.  Since  mechanical  integrity  is  of  paramount 
importance in successful formulation of RDTs, hence the 
hardness of tablets was determined and was found to be 
in the range of 2.8 to 4.3 Kg/cm
2. Friability was observed 
between  0.12  to  0.22%,  which  were  below  0.5  to  1% 
indicating sufficient mechanical integrity and strength of 
the prepared tablets. Thus,  hardness and  friability data 
indicates good mechanical resistance of tablets. In- vitro 
disintegration time for different batches of RDTs was 32 
to  73  seconds  respectively.  The  tablet  formulations 
containing  Crospovidone  and  Croscarmellose  sodium 
alone  at low concentration (8mg/tablet) showed higher 
values of 47 to 73 seconds  for in- vitro disintegration 
time. Hence the batch F2 was used for further studies like 
wetting time, wetting volume, dissolution profile study. 
Wetting time was determined to get idea of wetting lag 
time before disintegration. The wetting time for batch F2 
was 52 seconds, which shows that very small amount of 
water  is  required  for  wetting  of  tablet.  It  has  been 
reported  that  wetting  is  closely  related  to  the  inner 
structure  of  the  tablets  and  the  hydrophilicity  of  the 
excipients,  crospovidone  and  Croscarmellose  sodium 
show  its  disintegrant  effect  by  the  mechanism  of 
swelling.  Thus  these  results  indicate  that  these  tablets 
would disintegrate almost instantaneously when they will 
come in contact with even slight quantity of saliva in the 
mouth. 
The cumulative percentage drug release from pure drug, 
prepared RDT batch F2 and marketed conventional tablet 
formulation is shown in Table 4. It was observed that in 
first 10 minutes, only 2.0 % drug was released from pure 
drug and marketed conventional tablet formulation while 
it was 89.0 % in case of RDT. At the end of 30 minutes, 
98.0 % of drug was released from the batch F2. Thus the 
release  rate  of  Ondansetron  hydrochloride  was 
significantly  enhanced  by  formulating  RDTs  by  using 
superdisintegrants. 
CONCLUSION 
Rapid  disintegrating  tablets  of  Ondansetron 
hydrochloride  were  prepared  by  direct  compression 
method using crospovidone and croscarmellose sodium 
as superdisintegrants. The tablets disintegrated rapidly in 
oral cavity and had acceptable hardness and friability. In 
vitro  drug  release  from  the  tablets  shows  significantly 
improved drug dissolution. Hence it could be concluded 
that  the  superdisintegrants  based  rapid  disintegrating 
tablets  of  Ondansetron  hydrochloride  would  be  quite 
effective  in  emesis,  providing  quick  onset  of  action 
without need for water for swallowing or administration. 
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Table: 1 Formulation of rapid disintegrating Ondansetron hydrochloride 
Tablets 
 
Ingredients  F1 
(mg) 
F2 
(mg) 
F3 
(mg) 
F4 
(mg) 
F5 
(mg) 
F6 
(mg) 
Ondansetron 
Eudragit EPO 
mixture 
 
13 
 
13 
 
13 
 
13 
 
13 
 
13 
Microcrystalline 
cellulose 
25 
 
27 
 
20 
 
25 
 
27 
 
20 
 
Mannitol  96  65.25  76  102  80  95 
Croscarmellose  
Sodium 
6 
 
8  10 
 
- 
 
- 
 
- 
 
Crospovidone  -    -  6  8  10 
Aspartame  4  -  4  4  3  3 
Flavour  3  3  2.5  2  3  2 
Colloidal 
Silicon dioxide 
5 
 
3.75  5 
 
5 
 
3.75 
 
3.75 
 
 
Magnesium 
stearate 
 
10 
 
10 
 
10 
 
10 
 
10 
 
10 
 
Table 2: Evaluation of RDT of Ondansetron HCL 
 
Batch 
code 
Weight 
variation 
Thickness 
(mm) 
Hardness 
(kg/cm
2) 
Friability 
(%) 
In-vitro 
Disin. Time 
(sec) 
Assay (%)  Wetting 
time 
(sec) 
F-1  5.7± 0.51  4.11  3.1  0.18  73  98.98  70 
F-2  6.0± 0.22  4.18  2.85  0.12  32  100.84  52 
F-3  5.5± 0.34  4.15  3.5  0.22  43  99.25  46 
F-4  5.0± 0.10  4.14  4.3  0.16  47  99.45  53 
F-5  5.4± 0.30  4.16  4.1  0.17  38  99.58  64 
F-6  5.0± 0.54  4.18  3.8  0.18  34  100.65  37 
The data are expressed as mean±S.D. (n=3) 
 
 
Table 3: Percent drug release from RDT of Ondansetron Formulations 
 
Time 
(min). 
Cumulative percent drug release 
  F1   F2  F3  F4  F5  F6 
0  0.000  0.000  0.000  0.000  0.000  0.000 
1  3.947  4.605  2.212  3.467  4.820  4.102 
2  23.206  49.350  19.219  15.796  20.215  23.789 
3  39.180  89.262  35.014  23.206  37.018  45.180 
4  41.451  91.230  46.738  29.871  48.731  55.120 
5  49.000  95.080  51.467  33.110  50.551  64.142 
6  59.045  98.380  59.149  35.180  60.189  78.086 
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Table 4: Percent Drug Release from prepared tablet and marketed product 
 
Time 
(min.) 
Cumulative % Drug Release 
  prepared tablet  marketed tablet 
0  0  0 
5  4.60  3.032 
10  49.35  42.48 
15  89.26  71.88 
20  91.23  82.56 
25  95.08  90.28 
30  98.38  96.89 
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Figure 1: Comparatives Study of Percent Disintegration in Different 
Formulations 
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Fig. 2: Comparative % drug release from all formulation 
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Fig. 3: Comparative % drug release from prepared batch F2 and Marketed 
product 
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